EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Concurrent Anti-PR3 Immunoassay and cANCA Indirect Immunofluorescence Testing Provide Complementary Information for Clinical Laboratory Detection of Antineutrophil Cytoplasmic Antibodies

Reagan Badger, Susan L Fink iD, Kathleen Hutchinson, Mark H Wener iD, Chihiro Morishima iD, Rebecca S Treger iD

The Journal of Applied Laboratory Medicine · 2026

DOI: 10.1093/jalm/jfaf168 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Applied Laboratory Medicine, 2026. Verfasst von Reagan Badger und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA, United States. Hauptthemen laut MEDLINE: Antibodies, Antineutrophil Cytoplasmic, Myeloblastin, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Multiplex immunoassays and indirect immunofluorescence assays (IFA) are frequently used for the detection of antineutrophil cytoplasmic antibodies (ANCA) but can produce differing results.

Methods

To understand the settings in which discordant results occur, we retrospectively investigated first-recorded cytoplasmic ANCA (cANCA) IFA and antiproteinase 3 (PR3) results (n = 15 772) generated over 4 years in our clinical laboratory.

Results

We detected significant bidirectional disagreement between cANCA and anti-PR3-antibody results that was not immunoassay or instrument specific. Sixteen percent (22/139) of cANCA-positive specimens were negative for anti-PR3 by multiplex immunoassay. Similarly, 61% (175/285) of anti-PR3 positive specimens were negative for cANCA by IFA. Borderline or indeterminate positivity thresholds could not fully explain the discrepancy between results, suggesting that patient-associated characteristics may contribute. Medical record review of patients with discordant testing over time revealed cANCA/anti-PR3 disagreement in patients with ANCA-associated vasculitis on chronic immunomodulatory therapy, suggesting a treatment-related phenomenon. Among 59% (13/22) of patients for whom serial ANCA testing was evaluated, cANCA semiquantitative titers and anti-PR3 antibody quantitative results trended together and correlated with disease activity in response to immunomodulatory therapy. However, asynchronous changes were observed in 41% (9/22) of patients, leading to significant differences in anti-PR3 or cANCA results despite sustained cANCA or anti-PR3 antibody negativity, respectively.

Conclusion

In certain individuals, anti-PR3 antibodies and cANCA titers may differentially capture disease activity, and cANCA/anti-PR3-discordant results may have clinical significance in the setting of immunomodulatory therapy. Our data argue for a complementary testing approach that implements both immunoassay and IFA methods to detect these changes over time.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Antineutrophil CytoplasmicMyeloblastinAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisHumansRetrospective StudiesFluorescent Antibody Technique, IndirectImmunoassayFemaleMaleMiddle AgedAged

Substanzen

Antibodies, Antineutrophil CytoplasmicMyeloblastin

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA, United States.
  • School of Medicine, University of Washington, Seattle, WA, United States.
  • Division of Rheumatology, University of Washington Medical Center, Seattle, WA, United States.

ORCID-Profile: Susan L Fink, Mark H Wener, Chihiro Morishima, Rebecca S Treger

Zitieren

APA

Badger, R., Fink, S. L., Hutchinson, K., Wener, M. H., Morishima, C., & Treger, R. S. (2026). Concurrent Anti-PR3 Immunoassay and cANCA Indirect Immunofluorescence Testing Provide Complementary Information for Clinical Laboratory Detection of Antineutrophil Cytoplasmic Antibodies. The Journal of Applied Laboratory Medicine. https://doi.org/10.1093/jalm/jfaf168

Vancouver

Badger R, Fink SL, Hutchinson K, Wener MH, Morishima C, Treger RS. Concurrent Anti-PR3 Immunoassay and cANCA Indirect Immunofluorescence Testing Provide Complementary Information for Clinical Laboratory Detection of Antineutrophil Cytoplasmic Antibodies. The Journal of Applied Laboratory Medicine. 2026. doi:10.1093/jalm/jfaf168

BibTeX
@article{Badger2026,
  author = {Badger, Reagan and Fink, Susan L and Hutchinson, Kathleen and Wener, Mark H and Morishima, Chihiro and Treger, Rebecca S},
  title = {Concurrent Anti-PR3 Immunoassay and cANCA Indirect Immunofluorescence Testing Provide Complementary Information for Clinical Laboratory Detection of Antineutrophil Cytoplasmic Antibodies},
  journal = {The Journal of Applied Laboratory Medicine},
  year = {2026},
  doi = {10.1093/jalm/jfaf168}
}
Kostenlos starten →